comparemela.com

Latest Breaking News On - Abbvie immunogen - Page 1 : comparemela.com

Genmab Buys ProfoundBio for $1.8B to Boost Oncology Portfolio

Danish drugmaker Genmab said Wednesday it plans to acquire U.S. biotech firm ProfoundBio for $1.8 billion in cash to expand its cancer treatment portfolio.

Denmark
Danish
Ambrx-biopharma
Abbvie-immunogen
Fusion-pharmaceuticals
Profoundbio-inc
Chief-executive-officer
Depositary-receipts

Federal Antitrust Enforcement in Health Care: 2023 Year in Review–Part 3 | Manatt, Phelps & Phillips, LLP

In 2023, the DOJ continued its aggressive criminal antitrust enforcement agenda in health care, with mixed results in labor markets. In speeches, the DOJ asserted that its commitment to.

California
United-states
Maine
Florida
American
Alex-kacik
Dan-papscun
Abbvie-immunogen
Dennis-hoey
Abbvie-cerevel
Phelps-phillips
Diane-bartz

Consumer Sentiment Rises as Inflation Expectations Fall

A 13% uptick in the University of Michigan consumer sentiment index bodes well. Plus, investment newsletter commentary on copper prices, stock-market gains,.

Japan
Michigan
United-states
China
Japanese
Roukaya-ibrahim
Udith-sikand
Timothy-brackett
Joanne-hsu
Michael-shaoul
Abbvie-immunogen
Jared-holz

AbbVie Pays $10.1 Billion for ImmunoGen to Expand Its Cancer Drug Portfolio

AbbVie is buying rival biotech firm ImmunoGen for $10.1 billion, giving it access to ImmunoGen's flagship ovarian cancer treatment.

Richard-gomez
Abbvie-immunogen

vimarsana © 2020. All Rights Reserved.